Ensysce Biosciences Inc

-0.06 (-8.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.14M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.4 Million
Adjusted EPS-$0.90
See more estimates
10-Day MA$0.76
50-Day MA$0.89
200-Day MA$1.32
See more pivots

Ensysce Biosciences Inc Stock, NASDAQ:ENSC

7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037
United States of America
Phone: +1.858.263.4196
Number of Employees:


Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.